BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 1, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 24, 2009
View Archived Issues
Universita di Bologna patents novel AChE and BChE inhibitors
Read More
GlaxoSmithKline presents novel muscarinic M1 receptor agonists
Read More
Novel gonadotropin-releasing hormone receptor antagonists claimed by Kissei
Read More
Solvay describes cannabinoid CB1 receptor agonists for pain treatment
Read More
Novel beta2-adrenoceptor agonists described by Sepracor for the treatment of bronchoconstriction
Read More
In vitro and phase I data on silymarin in hepatitis C presented
Read More
Travatan and DuoTrav show comparable efficacy in patients with primary open-angle glaucoma
Read More
Dual inhibitors of PI3K and mTOR with in vivo antitumor activity reported by Piramed and Genentech
Read More
MK-7009 combined with peginterferon, ribavirin in phase IIa study
Read More
Combination of filibuvir and peginterferon alfa-2a/ribavirin evaluated in HCV patients
Read More
Haptoglobin level a biomarker for gemcitabine-related hematological toxicities
Read More
MK-2206: Development through phase I study described
Read More
Immutep commences phase I ImmuFact IMP-321 trial in pancreatic cancer
Read More
Tranzyme reports positive phase II TZP-101 results in gastroparesis
Read More
FDA approves phase II trial for Bryostatin in Alzheimer's disease
Read More
Sanaria initiates phase I whole-parasite malaria vaccine trial
Read More
Acorda resubmits NDA for Fampridine-SR for improved walking in MS
Read More
Revlimid receives positive final appraisal determination for NHS
Read More
The caspase inhibitor GS-9450 well tolerated in phase I trial in healthy individuals
Read More
Molecular Sensing and VIB enter agreement in Alzheimer's disease research
Read More
NovaBay enters into agreement with the Medical University of Innsbruck
Read More
European Commission approves Removab for malignant ascites
Read More
Addrenex and Sciele report results for second phase III Clonicel study in ADHD
Read More
Dr. Reddy's launches Redispar in India for SHPT due to chronic kidney disease
Read More
Takeda discontinues TAK-379 development for diabetes
Read More
Vion receives an FDA standard review classification for Onrigin NDA
Read More
deCODE grants Celera licenses to risk markers for heart attack, stroke and diabetes
Read More
